Myelin oligodendrocyte glycoprotein antibody-associated disease

MONDO:1040024

A demyelinating disease of the central nervous system characterized by the presence of a demyelinating event (optic neuritis, myelitis, acute/multiphasic encephalomyelitis, cerebral or polyfocal deficits, brainstem or cerebellar deficits, and/or cerebral cortical encephalitis), a positive myelin oligodendrocyte glycorotein-IgG test, and exclusion of an alternative diagnosis like MS.

24 clinical trials for this condition and its sub-types, 22 tagged with Myelin oligodendrocyte glycoprotein antibody-associated disease itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Inflammatory disease (10862) ↑ Demyelinating disease of central nervous system (866)

Sub-types of Myelin oligodendrocyte glycoprotein antibody-associated disease

Acute disseminated encephalomyelitis with anti-MOG antibodies 0 trials
Acute transverse myelitis with anti-MOG antibodies 0 trials
Isolated optic neuritis with anti-MOG antibodies 0 trials
Neuromyelitis optica spectrum disorder with anti-MOG antibodies 0 trials

Including sub-types (24) Tagged with Myelin oligodendrocyte glycoprotein antibody-associated disease (22)

Trials to join now! 12 Not yet recruiting 4 Not yet finished but already full! 5 Completed 1

Study reveals vaccine response in Immune-Compromised patients

Knowledge-focused Completed

This study looked at how people with autoimmune diseases like multiple sclerosis or blistering skin conditions respond to COVID-19 vaccines while on B-cell depleting therapies. Researchers measured antibody levels and T-cell activity over time to understand vaccine effectiveness …

Sponsor: Yale University • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:38 UTC

Myelin oligodendrocyte glycoprotein antibody-associated disease

Where it sits in the disease tree

Study reveals vaccine response in Immune-Compromised patients